Literature DB >> 14986021

Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma.

Xavier León1, Antonio López-Pousa, Manuel de Vega, César Orús, Manuel de Juan, Miquel Quer.   

Abstract

An alternative treatment in patients with advanced laryngeal carcinoma who are candidates for total laryngectomy is induction chemotherapy and radical radiotherapy in an organ preservation approach. We conducted a study to evaluate results of this treatment in patients with locally advanced laryngeal carcinoma, candidates for total laryngectomy, who were treated at a single institution between 1985 and 1997. During the study period, 224 began treatment with induction chemotherapy. Induction chemotherapy consisted of three cycles of cisplatin and 5-fluoruracil in the majority of cases. Four patients died as a consequence of complications associated with chemotherapy treatment. Subsequent treatment consisted of total laryngectomy in 79 patients and radical radiotherapy in 141. After radical radiotherapy, local control for patients who achieved a complete response after induction chemotherapy was 74%, significantly better than 57% in patients with a non-complete response (P=0.04). Considering the initial group of 224 patients, the frequency of organ preservation was 39%. Considering only the patients treated with induction chemotherapy and radiotherapy, the organ preservation frequency was 62%. In a multivariate study, only the response after induction chemotherapy was significantly related to organ preservation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986021     DOI: 10.1007/s00405-004-0749-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  11 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.

Authors:  J L Lefebvre; D Chevalier; B Luboinski; A Kirkpatrick; L Collette; T Sahmoud
Journal:  J Natl Cancer Inst       Date:  1996-07-03       Impact factor: 13.506

4.  Randomized trial of induction chemotherapy in larynx carcinoma.

Authors:  J M Richard; H Sancho-Garnier; J J Pessey; B Luboinski; J L Lefebvre; D Dehesdin; M Stromboni-Luboinski; C Hill
Journal:  Oral Oncol       Date:  1998-05       Impact factor: 5.337

5.  Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders.

Authors:  O Laccourreye; D Veivers; S Hans; M Ménard; D Brasnu; H Laccourreye
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

6.  Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas.

Authors:  C Beauvillain; M Mahé; S Bourdin; P Peuvrel; P Bergerot; A Rivière; J Vignoud; D Deraucourt; M Wesoluch
Journal:  Laryngoscope       Date:  1997-05       Impact factor: 3.325

7.  Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.

Authors:  J B Lecanu; G Monceaux; S Périé; B Angelard; J L St Guily
Journal:  Laryngoscope       Date:  2000-03       Impact factor: 3.325

8.  Neoadjuvant therapy for organ preservation in head and neck cancer.

Authors:  S G Urba; G T Wolf; C R Bradford; A F Thornton; A Eisbruch; J E Terrell; V Carpenter; T Miller; G Tang; M Strawderman
Journal:  Laryngoscope       Date:  2000-12       Impact factor: 3.325

9.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

10.  Relation between responses to induction chemotherapy and subsequent radiotherapy in advanced or multicentric squamous cell carcinomas of the head and neck.

Authors:  X Panis; P Coninx; T D Nguyen; M Legros
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-06       Impact factor: 7.038

View more
  3 in total

1.  Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol.

Authors:  Xavier León; Cristina Valero; Carlota Rovira; Camilo Rodriguez; Montserrat López; Jacinto García-Lorenzo; Miquel Quer
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-27       Impact factor: 2.503

2.  Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay.

Authors:  Jung-Hee Lee; Dongil Sun; Kwang-Jae Cho; Min-Sik Kim; Myung-Hwa Hong; In-Kyung Kim; Jae-Seon Lee; Jeong-Hwa Lee
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-12       Impact factor: 4.553

3.  A Study of Peripheral Blood Parameters to Predict Response to Induction Chemotherapy and Overall Survival in Advanced Laryngeal Squamous Cell Carcinoma.

Authors:  Jiaqi Xu; Yifan Yang; Qi Zhong; Lizhen Hou; Hongzhi Ma; Yang Zhang; Ling Feng; Shizhi He; Meng Lian; Jugao Fang; Ru Wang
Journal:  Curr Oncol       Date:  2022-09-09       Impact factor: 3.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.